Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1628225rdf:typepubmed:Citationlld:pubmed
pubmed-article:1628225lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:1628225lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:1628225lifeskim:mentionsumls-concept:C1516031lld:lifeskim
pubmed-article:1628225lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:1628225lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:1628225lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:1628225pubmed:issue4lld:pubmed
pubmed-article:1628225pubmed:dateCreated1992-8-17lld:pubmed
pubmed-article:1628225pubmed:abstractTextA comparative study of two different species of a fluorouracil assay was conducted on 11 patients who had carcinoma that was deemed unresectable after the surgical operation. For these patients FU at a dose of 10 mg/kg was intravenously administered before operation, and portions of the tumors were resected within 120-150 min to assay both the (FU)RNA/RNA and FU/protein. After surgery, all patients were given FU alone either intravenously or orally. The FU, which was in an acid-soluble material (FU/protein), was not related to the antitumor effect of FU. However, the FU in RNA [(FU)RNA/RNA)] was found to be related to the antitumor effect of FU. When the concentration of (FU)RNA/RNA was above approximately 200 ng/mg, FU was effectual in unresectable carcinomas. It is probable that the (FU)RNA/RNA may be more suitable than FU/protein for predicting the antitumor effect of FU.lld:pubmed
pubmed-article:1628225pubmed:languageenglld:pubmed
pubmed-article:1628225pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1628225pubmed:citationSubsetIMlld:pubmed
pubmed-article:1628225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1628225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1628225pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1628225pubmed:statusMEDLINElld:pubmed
pubmed-article:1628225pubmed:issn0735-7907lld:pubmed
pubmed-article:1628225pubmed:authorpubmed-author:AkiyoshiTTlld:pubmed
pubmed-article:1628225pubmed:authorpubmed-author:MatsuokaHHlld:pubmed
pubmed-article:1628225pubmed:authorpubmed-author:SugimachiKKlld:pubmed
pubmed-article:1628225pubmed:authorpubmed-author:UeoHHlld:pubmed
pubmed-article:1628225pubmed:issnTypePrintlld:pubmed
pubmed-article:1628225pubmed:volume10lld:pubmed
pubmed-article:1628225pubmed:ownerNLMlld:pubmed
pubmed-article:1628225pubmed:authorsCompleteYlld:pubmed
pubmed-article:1628225pubmed:pagination265-9lld:pubmed
pubmed-article:1628225pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:meshHeadingpubmed-meshheading:1628225-...lld:pubmed
pubmed-article:1628225pubmed:year1992lld:pubmed
pubmed-article:1628225pubmed:articleTitlePreliminary evidence that incorporation of 5-fluorouracil into RNA correlates with antitumor response.lld:pubmed
pubmed-article:1628225pubmed:affiliationDepartment of Surgery, Kyushu University, Beppu, Japan.lld:pubmed
pubmed-article:1628225pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1628225pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1628225lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1628225lld:pubmed